Different expression of 11β-hydroxylase and aldosterone synthase between aldosterone-producing microadenomas and macroadenomas

Hypertension

Volumn 64, Issue 2, 2014, Pages 438-444

  Ono, Yoshikiyo ^a,b   Nakamura, Yasuhiro ^b   Maekawa, Takashi ^b   Felizola, Saulo J A ^b   Morimoto, Ryo ^a   Iwakura, Yoshitsugu ^a   Kudo, Masataka ^a   Seiji, Kazumasa ^b   Takase, Kei ^b   Arai, Yoichi ^b   Gomez Sanchez, Celso E ^a,c,d   Ito, Sadayoshi ^a   Sasano, Hironobu ^b   Satoh, Fumitoshi ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b Department of Pathology ^*  (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

adrenocortical adenoma; CYP11B1; CYP11B2; hyperaldosteronism; hypertension; immunohistochemistry

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; ANTIHYPERTENSIVE AGENT; CREATININE; HYDROCORTISONE; POTASSIUM; RENIN; STEROID 11BETA MONOOXYGENASE; STEROID 17ALPHA MONOOXYGENASE;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ALDOSTERONE URINE LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOKALEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LAPAROSCOPIC SURGERY; MALE; MICROADENOMA; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STEROIDOGENESIS; SYSTOLIC BLOOD PRESSURE; TUMOR VOLUME; URINARY EXCRETION;

ADRENOCORTICAL ADENOMA; CYP11B1; CYP11B2; HYPERALDOSTERONISM; HYPERTENSION; IMMUNOHISTOCHEMISTRY;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOOD PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STEROID 11-BETA-HYDROXYLASE;

EID: 84904512396     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.02944     Document Type: Article

References (29)

1. Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab. 2000;85:1863-1867.
2. Stowasser M, Gordon RD. Primary aldosteronism-careful investigation is essential and rewarding. Mol Cell Endocrinol. 2004;217:33-39.
3. Nishikawa T, Omura M, Satoh F, Shibata H, Takahashi K, Tamura N, Tanabe A; Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009. Endocr J. 2011;58:711-721.
4. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892-896.
5. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243-1248.
6. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M; Participants of the German Conn's Registry. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab. 2009;94:1125-1130.
7. Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, Arai Y, Nakamura Y, Sasano H, Ito S, Satoh F. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab. 2014;99:1586-1588.
8. Mulatero P, Monticone S, Rainey WE, Veglio F, Williams TA. Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol. 2013;9:104-112.
9. Lim PO, Young WF, MacDonald TM. A review of the medical treatment of primary aldosteronism. J Hypertens. 2001;19:353-361.
10. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
11. Kempers MJ, Lenders JW, van Outheusden L, van der Wilt GJ, Schultze Kool LJ, Hermus AR, Deinum J. Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med. 2009;151:329-337.
12. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery. 2004;136:1227-1235.
13. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res. 2006;29:883-889.
14. Karashima S, Takeda Y, Cheng Y, Yoneda T, Demura M, Kometani M, Ohe M, Mori S, Yagi K, Yamagishi M. Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma. Steroids. 2011;76:1363-1366.
15. Ishidoya S, Kaiho Y, Ito A, Morimoto R, Satoh F, Ito S, Ishibashi T, Nakamura Y, Sasano H, Arai Y. Single-center outcome of laparoscopic unilateral adrenalectomy for patients with primary aldosteronism: lateralizing disease using results of adrenal venous sampling. Urology. 2011;78:68-73.
16. Satoh F. Localization of aldosterone-producing adrenocortical adenomas-significance of adrenal venous sampling. Hypertens Res. 2007;30:1083-1095.
17. Czarkowski M, Staszków M, Kostyra K, Shebani Z, Niemczyk S, Matuszkiewicz-Rowiska J. Determining the accuracy of blood pressure measurement by the Omron HEM-907 before and after hemodialysis. Blood Press Monit. 2009;14:232-238.
18. Matsuura T, Takase K, Ota H, Yamada T, Sato A, Satoh F, Takahashi S. Radiologic anatomy of the right adrenal vein: preliminary experience with MDCT. AJR Am J Roentgenol. 2008;191:402-408.
19. Sasano H, Mason JI, Sasano N, Nagura H. Immunolocalization of 3̀-hydroxysteroid dehydrogenase in human adrenal cortex and in its disorders. Endocr Pathol. 1990;1:94-101.
20. Sasano H, Mason JI, Sasano N. Immunohistochemical study of cytochrome P-45017 alpha in human adrenocortical disorders. Hum Pathol. 1989;20:113-117.
21. Gomez-Sanchez CE, Qi X, Velarde-Miranda C, Plonczynski MW, Parker CR, Rainey W, Satoh F, Maekawa T, Nakamura Y, Sasano H, Gomez-Sanchez EP. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 2014;383:111-117.
22. Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS Jr. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986;46:5419-5425.
23. Bassett MH. The orphan nuclear receptors Nurr1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol. 2003;18:279-290.
24. Ye P, Nakamura Y, Lalli E, Rainey WE. Differential effects of high and low steroidogenic factor-1 expression on CYP11B2 expression and aldosterone production in adrenocortical cells. Endocrinology. 2009;150:1303-1309.
25. Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453-455.
26. Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, Satoh F, Young WF Jr. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151-160.
27. Azizan EA, Lam BY, Newhouse SJ, Zhou J, Kuc RE, Clarke J, Happerfield L, Marker A, Hoffman GJ, Brown MJ. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa-and zona fasciculatalike tumors. J Clin Endocrinol Metab. 2012;97:E819-E829.
28. Scholl UI, Goh G, Stölting G, et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet. 2013;45:1050-1054.
29. Williams TA, Monticone S, Schack VR, et al. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas. Hypertension. 2014;63:188-195.